Celebrate Your Success with SeqStudio Flex
SeqStudio Flex 1st Anniversary bundle promotion and the landing page are live now!
To celebrate the progress and success of researchers working with the SeqStudio Flex Genetic Analyzer in the first year since launch, Thermo Fisher Scientific is providing a special promotion for customers to adopt SeqStudio Flex in a more cost-effective way.
New MicroSEQ ID Microbial Identification Software v4.0 Launch
The Smart Deep Basecaller (SDB) is an innovative new basecalling algorithm that allows you to obtain improved Sanger sequencing output with reduced manual review time. Check it out!
Invivoscribe Announces IVDR Approval of the LeukoStrat® CDx FLT3 Mutation Assay for CE
We look forward to expanded customer usage of this fragment-analysis based assay that is approved for use on the 3500xL Dx genetic analyzer (IVDR-approved May 11, 2023, FDA-approved 2020).
The LeukoStrat CDx FLT3 Mutation Assay is a fragment analysis-based in vitro diagnostic test designed to detect internal tandem duplications (ITD) and tyrosine kinase domain (TKD) mutations D835 and I836 in the FLT3 gene in genomic DNA extracted from patients diagnosed with acute myelogenous leukemia (AML). FLT3 somatic variants are among the most common driver mutations as is one of the strongest predictors of overall survival in acute myeloid leukemia (AML), the deadliest form of leukemia.
You can read press release here.